Detalhe da pesquisa
1.
Early-onset stroke and vasculopathy associated with mutations in ADA2.
N Engl J Med
; 370(10): 911-20, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552284
2.
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Curr Rheumatol Rep
; 19(11): 70, 2017 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983775
3.
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.
J Pediatr
; 177: 316-320, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27514238
4.
Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation.
Proc Natl Acad Sci U S A
; 108(5): 2088-93, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21245324
5.
Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.
Proc Natl Acad Sci U S A
; 107(32): 14351-6, 2010 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20660758
6.
Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
J Allergy Clin Immunol
; 138(2): 628-630.e2, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27130863
7.
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
J Allergy Clin Immunol
; 135(1): 283-7.e5, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25457153
8.
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
Arthritis Rheumatol
; 73(3): 512-519, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021335
9.
SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience.
Rheumatology (Oxford)
; 49(4): 823-4, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965977
10.
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients.
Arthritis Res Ther
; 16(2): R63, 2014 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24602182
11.
Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
Arthritis Rheum
; 56(3): 1021-8, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17328081
12.
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
Arthritis Res Ther
; 8(1): R12, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16356199
13.
Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.
J Am Soc Nephrol
; 12(5): 1001-1009, 2001 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11316859